Sildenafil shows potential to inhibit cancer metastasis by blocking cholesterol access

A collaborative study by Israeli and U.S. researchers indicates that sildenafil, commonly used for erectile dysfunction, may inhibit cancer metastasis by disrupting cholesterol metabolism in tumor cells. While the findings suggest a potential repurposing of the drug, the research is in early stages and requires clinical validation to confirm efficacy in human patients.